glp 1 and depression Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of | Pharmacological Reports GLP-1 Agonists Can Be Heaven
Description
The FDA approved Ozempic as an insulin-boosting treatment for Type 2 diabetes in 2017

Consistent tracking is the most reliable way to catch nutrient gaps before they become a problem self-reported intake is well documented to be inaccurate without some form of structured logging

[DOI] [PubMed] [Google Scholar] 117.Hammoud R, Drucker DJ

Funding This supplement has been sponsored by Hansa Medcell, India, who provided an unrestricted educational grant in support of the original project

For all their promise, GLP-1 and dual GIP/GLP-1 receptor agonists have raised more questions, particularly regarding their long-term safety implications
